Modelling BCR-ABL1 dynamics in patients with chronic myeloid leukemia in chronic phase (CML-CP) during frontline therapy with high-dose imatinib, nilotinib, or dasatinib Meeting Abstract


Authors: Olshen, A.; Quintas-Cardama, A.; Kantarjian, H. M.; Gonen, M.; Michor, F.; Cortes, J.
Abstract Title: Modelling BCR-ABL1 dynamics in patients with chronic myeloid leukemia in chronic phase (CML-CP) during frontline therapy with high-dose imatinib, nilotinib, or dasatinib
Meeting Title: 50th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 112
Issue: 11
Meeting Dates: 2008 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2008-11-16
Start Page: 1113
Language: English
ACCESSION: WOS:000262104703677
PROVIDER: wos
PUBMED: 22276298
DOI: 10.1182/blood.V112.11.3240.3240
Notes: --- - Meeting Abstract: 3240 - Poster Session - 50th Annual Meeting of the American-Society-of-Hematology - DEC 06-09, 2008 - San Francisco, CA - "Source: Wos"
Altmetric
Citation Impact
MSK Authors
  1. Mithat Gonen
    957 Gonen
  2. Adam B Olshen
    107 Olshen
  3. Franziska Michor
    23 Michor